Device Urology Gynecology

Olympus

Payments companies reported to CMS as associated with Olympus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2.4Massociated payments (2023-2025)

1,769clinicians with associated payments

6companies reporting

By year

2023 $664K

2024 $794K

2025 $978K

Payments reported as associated with Olympus, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $1.5M

Pulmonary Disease $194K

Orthopaedic Surgery $190K

Surgery $179K

Obstetrics & Gynecology $53K

Colon & Rectal Surgery $51K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Olympus

These are the largest totals companies reported as associated with Olympus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Derek Dee	Huntington Beach, CA	Orthopaedic Surgery	$189,127.87
Hiroyuki Aihara	Boston, MA	Gastroenterology (Internal Medicine)	$188,632.25
Dennis Yang	Orlando, FL	Gastroenterology (Internal Medicine)	$178,237.89
Sergey Kantsevoy	Baltimore, MD	Gastroenterology (Internal Medicine)	$174,307.84
Joo Hwang	Stanford, CA	Gastroenterology (Internal Medicine)	$172,635.88
Peter Draganov	Gainesville, FL	Gastroenterology (Internal Medicine)	$159,885.97
Makoto Nishimura	New York, NY	Gastroenterology (Internal Medicine)	$86,319.69
Ahmed Saeed	Kansas City, MO	Gastroenterology (Internal Medicine)	$77,295.95
Alexander Schlachterman	Philadelphia, PA	Gastroenterology (Internal Medicine)	$61,168.94
Alexander Chen	Saint Louis, MO	Pulmonary Disease	$54,496.73

Prescribed Olympus?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.